Predominance of KPC-3 in a survey for carbapenemase-producing Enterobacteriaceae in Portugal

Antimicrobial Agents and Chemotherapy
Vera ManageiroManuela Caniça

Abstract

Among the 2,105 Enterobacteriaceae tested in a survey done in Portugal, 165 were nonsusceptible to carbapenems, from which 35 (26 Klebsiella pneumoniae, 3 Escherichia coli, 2 Enterobacter aerogenes, and 3 Enterobacter cloacae isolates and 1 Klebsiella oxytoca isolate) were confirmed to be carbapenemase producers by the presence of 30 Tn4401d-blaKPC-3, 4 intI3-blaGES-5, and one intI1-blaVIM-2 gene, alone or in combination with other bla genes. The dissemination of blaKPC-3 gene carried by an IncF plasmid suggests lateral gene transfer as a major mechanism of dissemination.

References

Aug 26, 2003·Antimicrobial Agents and Chemotherapy·Mário CorreiaAida Duarte
Dec 24, 2004·Antimicrobial Agents and Chemotherapy·T ConceiçãoR Barros
Jun 7, 2005·Journal of Microbiological Methods·Alessandra CarattoliE John Threlfall
Oct 27, 2006·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·UNKNOWN European Committee on Antimicrobial Susceptibility Testing (EUCAST) Steering Committee
Sep 18, 2009·Journal of Clinical Microbiology·Tommaso GianiGian Maria Rossolini
Jun 8, 2010·The Journal of Antimicrobial Chemotherapy·Laurent PoirelPatrice Nordmann
Jul 6, 2010·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·C G GiskeN Woodford
Jul 28, 2010·Antimicrobial Agents and Chemotherapy·Brandon KitchelJean B Patel
Mar 17, 2011·The Journal of Antimicrobial Chemotherapy·L F MatasejeM R Mulvey
Jul 29, 2011·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·A-P MagiorakosD L Monnet
Oct 18, 2011·Emerging Infectious Diseases·Patrice NordmannLaurent Poirel
Apr 18, 2012·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·R CantónUNKNOWN European Network on Carbapenemases
Mar 19, 2013·International Journal of Medical Microbiology : IJMM·Alessandra Carattoli
May 3, 2013·Journal of Clinical Microbiology·Louis-Patrick HaraouiMark A Miller
Jul 23, 2013·Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin·C GlasnerUNKNOWN European Survey on Carbapenemase-Producing Enterobacteriaceae (EuSCAPE) Working Group
Aug 13, 2013·The Journal of Antimicrobial Chemotherapy·Carla RodriguesLuísa Peixe
Nov 26, 2013·FEMS Microbiology Letters·Vera ManageiroCélia M Manaia
Mar 19, 2014·Proceedings of the National Academy of Sciences of the United States of America·Frank R DeleoBarry N Kreiswirth

❮ Previous
Next ❯

Citations

Dec 18, 2015·Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin·Barbara AlbigerUNKNOWN European Survey of Carbapenemase-Producing Enterobacteriaceae (EuSCAPE) working group
May 6, 2016·The Journal of Antimicrobial Chemotherapy·Adriana OrtegaUNKNOWN Spanish Collaborating Group for the Antibiotic Resistance Surveillance Programme
Sep 30, 2016·Frontiers in Microbiology·Daniela Jones-DiasManuela Caniça
Oct 30, 2016·Epidemiology and Infection·D VubilG J DA Silva
Jul 21, 2017·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Carla RodriguesLuísa Peixe
Apr 5, 2019·Journal of Clinical Microbiology·Cátia MarquesConstança Pomba
Aug 31, 2019·Annals of the New York Academy of Sciences·Katlego KopotsaNontombi Marylucy Mbelle
May 5, 2017·The Journal of Antimicrobial Chemotherapy·Yosra ManiMarisa Haenni
Mar 20, 2018·Emerging Infectious Diseases·Ana Constança MendesLuísa Peixe
Aug 24, 2019·Emerging Infectious Diseases·Marta Aires-de-SousaLaurent Poirel
Dec 15, 2020·International Journal of Antimicrobial Agents·Marta Hernández-GarcíaUNKNOWN STEP study group

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America
J Kristie JohnsonMaryland Multidrug-Resistant Organism Prevention Collaborative
© 2021 Meta ULC. All rights reserved